Literature DB >> 12509446

mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation.

Susan M Mendrysa1, Matthew K McElwee, Jennifer Michalowski, Kathleen A O'Leary, Karen M Young, Mary Ellen Perry.   

Abstract

The function of the p53 tumor suppressor protein must be highly regulated because p53 can cause cell death and prevent tumorigenesis. In cultured cells, the p90MDM2 protein blocks the transcriptional activation domain of p53 and also stimulates the degradation of p53. Here we provide the first conclusive demonstration that p90MDM2 constitutively regulates p53 activity in homeostatic tissues. Mice with a hypomorphic allele of mdm2 revealed a heretofore unknown role for mdm2 in lymphopoiesis and epithelial cell survival. Phenotypic analyses revealed that both the transcriptional activation and apoptotic functions of p53 were increased in these mice. However, the level of p53 protein was not coordinately increased, suggesting that p90MDM2 can inhibit the transcriptional activation and apoptotic functions of p53 in a manner independent of degradation. Cre-mediated deletion of mdm2 caused a greater accumulation of p53, demonstrating that p90MDM2 constitutively regulates both the activity and the level of p53 in homeostatic tissues. The observation that only a subset of tissues with activated p53 underwent apoptosis indicates that factors other than p90(MDM2) determine the physiological consequences of p53 activation. Furthermore, reduction of mdm2 in vivo resulted in radiosensitivity, highlighting the importance of mdm2 as a potential target for adjuvant cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509446      PMCID: PMC151546          DOI: 10.1128/MCB.23.2.462-473.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

Authors:  K F Macleod; N Sherry; G Hannon; D Beach; T Tokino; K Kinzler; B Vogelstein; T Jacks
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

2.  Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.

Authors:  T Juven; Y Barak; A Zauberman; D L George; M Oren
Journal:  Oncogene       Date:  1993-12       Impact factor: 9.867

3.  The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice.

Authors:  A J Merritt; C S Potten; C J Kemp; J A Hickman; A Balmain; D P Lane; P A Hall
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

4.  Analysis of the degradation function of Mdm2.

Authors:  M H Kubbutat; R L Ludwig; A J Levine; K H Vousden
Journal:  Cell Growth Differ       Date:  1999-02

5.  Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice.

Authors:  T J McDonnell; R Montes de Oca Luna; S Cho; L L Amelse; A Chavez-Reyes; G Lozano
Journal:  J Pathol       Date:  1999-07       Impact factor: 7.996

6.  p53 status and the efficacy of cancer therapy in vivo.

Authors:  S W Lowe; S Bodis; A McClatchey; L Remington; H E Ruley; D E Fisher; D E Housman; T Jacks
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

8.  Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.

Authors:  D A Freedman; A J Levine
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

10.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  101 in total

1.  An Integrated Genetic-Genomic Approach for the Identification of Novel Cancer Loci in Mice Sensitized to c-Myc-Induced Apoptosis.

Authors:  Susan M Mendrysa; Keiko Akagi; Jean Roayaei; Wen-Hui Lien; Neal G Copeland; Nancy A Jenkins; Robert N Eisenman
Journal:  Genes Cancer       Date:  2010-05

2.  NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.

Authors:  Valere Busuttil; Nathalie Droin; Laura McCormick; Francesca Bernassola; Eleonora Candi; Gerry Melino; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

3.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

4.  A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.

Authors:  Sean M Post; Alfonso Quintás-Cardama; Vinod Pant; Tomoo Iwakuma; Amir Hamir; James G Jackson; Daniela R Maccio; Gareth L Bond; David G Johnson; Arnold J Levine; Guillermina Lozano
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

Review 5.  Tied up in loops: positive and negative autoregulation of p53.

Authors:  Xin Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

6.  Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death.

Authors:  Panagiota A Sotiropoulou; Aurélie Candi; Guilhem Mascré; Sarah De Clercq; Khalil Kass Youssef; Gaelle Lapouge; Ellen Dahl; Claudio Semeraro; Geertrui Denecker; Jean-Christophe Marine; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

7.  The ups and downs of p53 regulation in hematopoietic stem cells.

Authors:  Hussein A Abbas; Vinod Pant; Guillermina Lozano
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

8.  E3 ubiquitin ligase MDM2 acts through p53 to control respiratory progenitor cell number and lung size.

Authors:  Pengfei Sui; Rongbo Li; Yan Zhang; Chunting Tan; Ankur Garg; Jamie M Verheyden; Xin Sun
Journal:  Development       Date:  2019-12-16       Impact factor: 6.868

Review 9.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

10.  Guilty as CHARGED: p53's expanding role in disease.

Authors:  Jeanine L Van Nostrand; Laura D Attardi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.